Nicole Germino
Stock Analyst at Truist Securities
(0)
# 4112
Out of 5,293 analysts
27
Total ratings
23.08%
Success rate
-8.58%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
YMAB Y-mAbs Therapeutics | Maintains: Buy | 21 18 | 4.5 | 300% | 2 | Mar 5, 2025 | |
INSM Insmed | Maintains: Strong Buy | 105 108 | 72 | 50% | 8 | Feb 21, 2025 | |
SGMO Sangamo Therapeutics | Maintains: Buy | 7 5 | 0.57 | 777.19% | 5 | Jan 23, 2025 | |
CATX Perspective Therapeu... | Initiates Coverage On: Buy | 21 | 1.95 | 976.92% | 1 | Sep 25, 2024 | |
FUSN Fusion Pharmaceutica... | Downgrades: Hold | 11 21 | n/a | n/a | 3 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 13 13 | n/a | n/a | 3 | Oct 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 132 24 | 9.32 | 157.51% | 3 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Sep 3, 2021 |